Wockhardt receives USFDA approval for generic version of Wyeth Zosyn
Wockhardt has received USFDA approval to market generic version of Wyeth’s Zosyn, used for treating bacterial infections, in the American market. Wockhardt Bio AG had […]
FDA
Glenmark Pharma receives USFDA approval for clobetasol propionate
Glenmark Pharmaceuticals has received USFDA approval for Clobetasol Propionate Ointment used for treatment of various skin conditions. The approved product is a generic version of […]
Lupin receives USFDA approval for sodium sulfate/potassium sulfate and magnesium sulfate
Lupin Ltd has received final USFDA approval to market sodium sulfate, potassium sulfate, magnesium sulfate oral solution used in colonoscopy. The company will market sodium […]
Mylan and Biocon receives USFDA approval for BLA for MYL-1401H
Mylan Pharma has received USFDA approval for its biologics licence application (BLA) for MYL-1401H, a proposed biosimilar Pegfilgrastim. The proposed biosimilar Pegfilgrastim is one of […]
Zydus Cadila receives USFDA approval for fluconazole
Zydus Cadila has received final USFDA approval to market fluconazole tablets used for the treatment of fungal infections in USA market. The company also received […]
Lupin receives USFDA approval for triamcinolone acetonide cream
Lupin has received final approval from USFDA to market its generic version of Mylan’s triamcinolone acetonide cream used for treatment of skin disease. The approval […]
Natco receives USFDA approval for Armodafinil
Natco Pharma has received final USFDA approval for generic Armodafinil tablets, used as wakefulness promoting agent. The company plans to market the same in US […]
Alembic Pharma receives USFDA approval for Zolmitriptan
Alembic Pharmaceuticals has received USFDA approval for Zolmitriptan Orally Disintegrating tablets, used for the treatment of migraine, in the American market. The product is therapeutically […]
Cipla to launch Entecavir tablet in USA
Cipla has received final USFDA approval to market Entecavir tablets used for treatment of Hepatitis B infection. The tablets are generic versions of Bristol-Myers Suibb’s […]
Alembic Pharma receives USFDA approval for Telmisartan and Amlodipine
Alembic Pharmaceuticals has received USFDA approval for its Telmisartan and Amlodipine tablets in the strengths of 40mg/5 mg, 40mg/10 mg, 80mg/5 mg and 80mg/10 mg, […]